Jay Kailash Namkeen Ltd vs Nath Bio Genes India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 21, 2026

Key Highlights

The Latest Trading Price of Jay Kailash Namkeen Ltd is ₹ 57.11 as of 21 Sep 15:32 . The P/E Ratio of Jay Kailash Namkeen Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 7.2 on March 2025 . This represents a CAGR of -2.21% over 3 years The Market Cap of Jay Kailash Namkeen Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 277.17 crore on March 2025 . This represents a CAGR of -9.07% over 4 years The revenue of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The ebitda of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The net profit of Jay Kailash Namkeen Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The Dividend Payout of Jay Kailash Namkeen Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 9.02 % on March 2025 . This represents a CAGR of 5.72% over 5 years .

About Jay Kailash Namkeen Ltd

Jay Kailash Namkeen Limited was originally incorporated on June 30, 2021 as 'Jay Kailash Namkeen (OPC) Private Limited' with the RoC.
Subsequently, Company had acquired the ongoing business of Proprietorship Firm, 'M/s.
Kailash Namkeen' via Business Transfer Agreement dated July 26, 2021, which changed the name of the Company to 'Jay Kailash Namkeen Private Limited' on May 25, 2022.
Finally, the status was converted into Public Company as 'Jay Kailash Namkeen Limited' vide fresh Certificate of Incorporation dated June 24, 2022 issued by the Registrar of Companies, Ahmedabad. Prior to incorporation of the Company, 'M/s.
Kailash Namkeen', a Proprietorship Firm, was founded by Nishitbhai Navinbhai Sonchhatra, which engaged in the business of manufacturing Namkeen in Rajkot, Gujarat.

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

FAQs for the comparison of Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd

Which company has a larger market capitalization, Jay Kailash Namkeen Ltd or Nath Bio-Genes (India) Ltd?

Market cap of Jay Kailash Namkeen Ltd is 30 Cr while Market cap of Nath Bio-Genes (India) Ltd is 281 Cr

What are the key factors driving the stock performance of Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd?

The stock performance of Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd?

As of September 21, 2026, the Jay Kailash Namkeen Ltd stock price is INR ₹60.11. On the other hand, Nath Bio-Genes (India) Ltd stock price is INR ₹148.0.

How do dividend payouts of Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd compare?

To compare the dividend payouts of Jay Kailash Namkeen Ltd and Nath Bio-Genes (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.